Related Experiment Videos
Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective
Patrick L Alore1, Walter M Jay, Mícheál P Macken
1Loyola University Medical Center, Maywood, IL 60153, USA.
Abstract:
Approved for the treatment of epilepsy and migraine prophylaxis, topiramate also acts as a carbonic anhydrase inhibitor implying a potential role in the treatment of pseudotumor cerebri (PTC). Topiramate has a propensity to cause anorexia with consequent weight loss, which alone may be curative in PTC. Prescribers must be aware of several reported cases of acute secondary angle-closure glaucoma reported in patients treated with topiramate.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Angle Closure Glaucoma: Treatment
Antiepileptic Drugs: Glutamate Antagonists
Psychosis: Goals of Pharmacotherapy